ATE345799T1 - Substituierte 4-phenyl-4-(1h-imidazol-2-yl)- piperidinderivate zur verringerung von ischämischer schädigung - Google Patents

Substituierte 4-phenyl-4-(1h-imidazol-2-yl)- piperidinderivate zur verringerung von ischämischer schädigung

Info

Publication number
ATE345799T1
ATE345799T1 AT02799040T AT02799040T ATE345799T1 AT E345799 T1 ATE345799 T1 AT E345799T1 AT 02799040 T AT02799040 T AT 02799040T AT 02799040 T AT02799040 T AT 02799040T AT E345799 T1 ATE345799 T1 AT E345799T1
Authority
AT
Austria
Prior art keywords
imidazole
phenyl
substituted
ischemic injury
piperidine derivatives
Prior art date
Application number
AT02799040T
Other languages
English (en)
Inventor
Frans Eduard Janssens
Joseph Elisabeth Leenaerts
Francisco Javi Fernandez-Gadea
Jarama S N Calle
Antonio Gomez-Sanchez
W Flameng
P Herijgers
Theo Frans Meert
Marcel J M Borgers
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE345799T1 publication Critical patent/ATE345799T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02799040T 2001-10-15 2002-10-10 Substituierte 4-phenyl-4-(1h-imidazol-2-yl)- piperidinderivate zur verringerung von ischämischer schädigung ATE345799T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01203927 2001-10-15

Publications (1)

Publication Number Publication Date
ATE345799T1 true ATE345799T1 (de) 2006-12-15

Family

ID=8181081

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02799040T ATE345799T1 (de) 2001-10-15 2002-10-10 Substituierte 4-phenyl-4-(1h-imidazol-2-yl)- piperidinderivate zur verringerung von ischämischer schädigung

Country Status (26)

Country Link
US (1) US7390822B2 (de)
EP (1) EP1438049B1 (de)
JP (1) JP4418676B2 (de)
KR (1) KR100967599B1 (de)
CN (1) CN1283252C (de)
AR (1) AR036800A1 (de)
AT (1) ATE345799T1 (de)
AU (1) AU2002363369B2 (de)
BR (1) BR0213325A (de)
CA (1) CA2462374C (de)
CY (1) CY1106335T1 (de)
DE (1) DE60216310T2 (de)
EA (1) EA007657B1 (de)
ES (1) ES2276980T3 (de)
HR (1) HRP20040325A2 (de)
HU (1) HUP0402332A3 (de)
IL (1) IL161347A0 (de)
MX (1) MXPA04003480A (de)
MY (1) MY139586A (de)
NO (1) NO20041681L (de)
NZ (1) NZ531733A (de)
PL (1) PL370371A1 (de)
PT (1) PT1438049E (de)
UA (1) UA75980C2 (de)
WO (1) WO2003039440A2 (de)
ZA (1) ZA200402816B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
AR044010A1 (es) * 2003-04-11 2005-08-24 Janssen Pharmaceutica Nv Uso de derivados de 4-fenil-4- [1h-imidazol-2-il]- piperidina sustituidos como agonistas delta opioideos no peptidos selectivos, con actividad antidepresiva y ansiolitica
WO2005005478A2 (en) * 2003-07-02 2005-01-20 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled opioid receptor; delta 1 (oprd1)
WO2005015242A1 (en) * 2003-08-06 2005-02-17 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled opioid receptor kappa 1 (opkr1)
TW200633990A (en) * 2004-11-18 2006-10-01 Takeda Pharmaceuticals Co Amide compound
DE502008003324D1 (de) * 2007-11-30 2011-06-01 Bayer Schering Pharma Ag Heteroaryl-substituierte piperidine
DE102009014484A1 (de) 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022896A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022894A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009056387B9 (de) * 2009-10-30 2020-05-07 Osram Opto Semiconductors Gmbh Kantenemittierender Halbleiterlaser mit einem Phasenstrukturbereich zur Selektion lateraler Lasermoden
HUE070649T2 (hu) 2017-10-19 2025-06-28 Teijin Pharma Ltd Benzimidazol-származékok és felhasználásuk
CN113209294B (zh) * 2020-02-05 2023-06-13 复旦大学 Dor激动剂在制备对抗肾脏纤维化药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2213000A1 (en) 1995-03-06 1996-09-12 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
CA2263890C (en) 1996-08-23 2013-05-14 Ludwig Institute For Cancer Research Recombinant vascular endothelial cell growth factor d (vegf-d)
JP2001524828A (ja) 1997-04-25 2001-12-04 コラテラル・セラピューティクス 切断型ｖｅｇｆ関連蛋白質
US6103722A (en) * 1997-07-23 2000-08-15 The Medical College Of Wisconsin Research Foundation Inc. Ischemic preconditioning
GB2332373A (en) * 1997-12-19 1999-06-23 Merck & Co Inc Treatment of coronary and/or peripheral ischemia using an antithrombotic agent and an angiogenesis promoter
HK1043128B (zh) * 1998-12-19 2007-01-19 詹森药业有限公司 抗组胺的螺环化合物
EP1038872A1 (de) * 1999-02-22 2000-09-27 Pfizer Products Inc. 4-Phenyl-4-heteroarylpiperdine Derivate als Opioid-Rezeptorligande
US6297256B1 (en) * 1999-06-15 2001-10-02 Neurogen Corporation Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands
ES2278065T3 (es) * 2001-10-15 2007-08-01 Janssen Pharmaceutica N.V. Nuevos derivados de 4-fenil-4-(1h-imidazol-2-il)-piperidina sustituida y su uso como agonistas selectivos de opioides delta no peptidos.
FR2831166B1 (fr) 2001-10-18 2004-02-27 Sanofi Synthelabo Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CA2462374C (en) 2011-01-18
EP1438049A2 (de) 2004-07-21
IL161347A0 (en) 2004-09-27
ZA200402816B (en) 2005-06-29
AR036800A1 (es) 2004-10-06
HUP0402332A3 (en) 2009-07-28
PL370371A1 (en) 2005-05-16
WO2003039440A2 (en) 2003-05-15
EA007657B1 (ru) 2006-12-29
HK1072562A1 (en) 2005-09-02
WO2003039440A3 (en) 2003-12-18
JP2005507943A (ja) 2005-03-24
MY139586A (en) 2009-10-30
ES2276980T3 (es) 2007-07-01
UA75980C2 (en) 2006-06-15
MXPA04003480A (es) 2004-07-30
DE60216310T2 (de) 2007-06-21
JP4418676B2 (ja) 2010-02-17
PT1438049E (pt) 2007-02-28
KR100967599B1 (ko) 2010-07-05
BR0213325A (pt) 2004-10-13
CN1283252C (zh) 2006-11-08
EP1438049B1 (de) 2006-11-22
US20050004170A1 (en) 2005-01-06
CN1568186A (zh) 2005-01-19
AU2002363369B2 (en) 2008-08-21
NZ531733A (en) 2006-04-28
US7390822B2 (en) 2008-06-24
NO20041681L (no) 2004-04-23
EA200400547A1 (ru) 2004-10-28
KR20050035120A (ko) 2005-04-15
HRP20040325A2 (en) 2005-04-30
DE60216310D1 (de) 2007-01-04
HUP0402332A2 (hu) 2005-02-28
CY1106335T1 (el) 2011-10-12
CA2462374A1 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
DE60211317D1 (de) Rho-kinase inhibitoren
DE60218138D1 (de) Rho-kinase inhibitoren
NO20026125D0 (no) Tetrahydropyridin- eller piperidin-heterocykliske derivater
PL3045175T3 (pl) Formy polimorficzne 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-ilo) -piperydyno-2,6-dionu
DE60222494D1 (de) Stabilisatorstab
DK1515969T3 (da) Spiroindolinpiperidinderivater
NO20032920D0 (no) Tynnere for inverterbare emulsjoner
NO20032921D0 (no) Tynnere for inverterbare emulsjoner
DE60216310D1 (de) Substituierte 4-phenyl-4-(1h-imidazol-2-yl)-piperidinderivate zur verringerung von ischämischer schädigung
IL155986A0 (en) 4- (biphenylcarbonylamino) piperidine derivatives as mtp inhibitors
NO20032807D0 (no) Substituerte 8-arylkinolin-fosfodiesterase-4-inhibitorer
DE60130137D1 (de) Kristallisationsverfahren
ATE315025T1 (de) Ethansulfonyl-piperidin-derivate
FI20011393L (fi) Menetelmä hissin investointikustannusten takaisinmaksamiseksi
FI20001655L (fi) Kiteytysmenetelmõ
ITUD20000151A0 (it) Centratore per levetappi
ATE285408T1 (de) Paroxetin-n-formyl-derivate
ATA13392000A (de) Holzblock zum errichten von wänden
DE60139781D1 (de) 4-substituierte piperidinverbindung
ATE355285T1 (de) In 3-position heterocyclisch substituierte piperidin-2,6-dione
DE60129124D1 (de) Verpackung zum festhalten von Gegenständen
ATA8612000A (de) Formwerkzeug zum spritzprägen
ATE360010T1 (de) Heterocyclische retioidverbindungen
UA5003S (uk) Стійка під штанги
FI20010357A0 (fi) Menetelmä puutavaran kuivaamiseksi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1438049

Country of ref document: EP